DoubleChecks

What was claimed

If you need an experimental new drug for rare cancer, you'll be going to Montana for miracle cures long before FDA approval

Our verdict

Needs caution

Montana has passed Senate Bill 535 allowing clinics to offer experimental drugs that have completed only Phase I trials and expanding right-to-try access beyond the terminally ill, positioning the state as a potential hub for experimental treatments. However, drugs must be manufactured in-state, efficacy is not yet established after Phase I, and there is no evidence that people with rare cancers generally "will" go to Montana for "miracle cures" before FDA approval, making the statement speculative and overstated. Phase I drugs are early-stage and unproven. Many fail in later clinical trials. Calling them 'miracle cures' overstates their efficacy and safety profile.

All 3 AI systems agree20 sources citedChecked Aug 1, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

Montana offers 'miracle cures' for experimental cancer drugs

Misleading85%
1 AI checked

Montana is the primary destination for experimental cancer treatments before FDA approval

Misleading85%
1 AI checked

If you need an experimental new drug for rare cancer, you'll be going to Montana for miracle cures long before FDA approval

Misleading87%
All 3 AIs agree

Montana allows access to experimental drugs that have completed Phase I but not FDA approval

Verified95%
1 AI checked

Verified against 20 sources

nbcmontana.comtrialx.commed.stanford.educancer.govsaintalphonsus.orgtrialx.comclinicaltrials.govmtcancer.orgmontanarightnow.comascopubs.orgfacebook.commedicalxpress.commskcc.orgrarediseases.orghealthcare.utah.edupolicylab.usrarediseaseadvisor.comvice.comtrial.medpath.comtargetcancer.org

Detailed Analysis

There is a new Montana law allowing access to some experimental drugs after only Phase I trials, but the statement exaggerates and generalizes this into guaranteed ‘miracle cures’ and a universal destination for rare cancer patients. The law has important limits, and current evidence does not support the sweeping implication made in the claim.

Why this verdict

  • There is a new Montana law allowing access to some experimental drugs after only Phase I trials, but the statement exaggerates and generalizes this into guaranteed ‘miracle cures’ and a universal destination for rare cancer patients.
  • The law has important limits, and current evidence does not support the sweeping implication made in the claim.

Claims checked

If you need an experimental new drug for rare cancer, you'll be going to Montana for miracle cures long before FDA approval

Misleading86%
Montana has passed Senate Bill 535 allowing clinics to offer experimental drugs that have completed only Phase I trials and expanding right-to-try access beyond the terminally ill, positioning the state as a potential hub for experimental treatments.[18] [19] However, drugs must be manufactured in-state, efficacy is not yet established after Phase I, and there is no evidence that people with rare cancers generally "will" go to Montana for "miracle cures" before FDA approval, making the statement speculative and overstated.[18] [19]

This claim may mislead readers without added context.

What other AI think

The claim contains accurate facts about Montana's SB 535 law enabling access to Phase I drugs, but significantly overstates Montana's necessity and uniqueness. Federal compassionate use and Right-to-Try pathways already exist nationwide. The term "miracle cures" is misleading since Phase I drugs are unproven and often fail in later trials.

Why this verdict

  • The claim contains accurate facts about Montana's SB 535 law enabling access to Phase I drugs, but significantly overstates Montana's necessity and uniqueness.
  • Federal compassionate use and Right-to-Try pathways already exist nationwide.
  • The term "miracle cures" is misleading since Phase I drugs are unproven and often fail in later trials.

Claims checked

Montana offers 'miracle cures' for experimental cancer drugs

Misleading85%
Phase I drugs are early-stage and unproven. Many fail in later clinical trials. Calling them 'miracle cures' overstates their efficacy and safety profile.

This claim may mislead readers without added context.

Montana is the primary destination for experimental cancer treatments before FDA approval

Misleading85%
While Montana's law is unique for commercialization, federal expanded access programs and Right-to-Try laws provide nationwide pathways that don't require traveling to Montana.

This claim may mislead readers without added context.

You need to go to Montana to access experimental cancer drugs before FDA approval

Misleading90%
Federal compassionate use and Right-to-Try pathways already exist nationwide. Montana is unique for commercialization speed, not for being the only access route to experimental drugs.

This claim may mislead readers without added context.

The statement is misleading. Montana has expanded 'Right to Try' laws making some investigational treatments available to patients before FDA approval, but access depends on specific legal criteria and manufacturer consent. It is incorrect to imply Montana is a guaranteed source of 'miracle cures' obtainable long before FDA approval.

Why this verdict

  • The statement is misleading.
  • Montana has expanded 'Right to Try' laws making some investigational treatments available to patients before FDA approval, but access depends on specific legal criteria and manufacturer consent.
  • It is incorrect to imply Montana is a guaranteed source of 'miracle cures' obtainable long before FDA approval.

Claims checked

If you need an experimental new drug for rare cancer, you'll be going to Montana for miracle cures long before FDA approval

Misleading86%
Montana’s law expands 'right to try' access to investigational treatments (usually post–Phase I), but companies must agree to provide drugs and risks/costs remain; this does not make Montana a reliable source of unapproved 'miracle cures.'

This claim may mislead readers without added context.

Share this result

Try DoubleChecks